[High incidence of asymptomatic myocardial ischemia in a population of HIV-infected patients in Bobo-Dioulasso, Burkina Faso].

Fréquence élevée de l´ischémie myocardique asymptomatique dans une population de patients infectés par le VIH à Bobo-Dioulasso, Burkina Faso.

Journal

The Pan African medical journal
ISSN: 1937-8688
Titre abrégé: Pan Afr Med J
Pays: Uganda
ID NLM: 101517926

Informations de publication

Date de publication:
2021
Historique:
received: 31 03 2016
accepted: 31 10 2016
entrez: 17 5 2021
pubmed: 18 5 2021
medline: 26 5 2021
Statut: epublish

Résumé

cardiovascular complications have become the 3 we conducted a descriptive cross-sectional study in November 2015. Asymptomatic HIV-1-infected patients on ARV treatment and followed up in the Day Hospital Unit of the Department of Infectious Diseases of the University Hospital Sanon Sourou of Bobo-Dioulasso were included in the study. Among enrolled patients data on cardiovascular risk factors were collected as well as two sitting blood pressure measurements after 10 minutes of rest were taken during consultations and resting 12-lead electrocardiogram (ECG) was performed. a total of 123 HIV-1-infected patients with a median age of 42 years (IQR: 36-50), among whom 79% were female subjects, were included in the study. Cardiovascular risk factors included: PAH (31.7%), obesity (33%), dyslipidemia (10.57%), active smoking (0.8%) and diabetes (0.8%). All patients with hypertension (5.7%) were insufficiently treated. The median duration of ARV treatment was 5.3 years (IQR: 3-7.7). Repolarization disorders were found in 26 cases (21.13%). They were divided into subepicardial ischaemia in 20 cases (16.26%), subendocardial damage in 2 cases (1.63%) and sequelae of necrosis in 4 cases (3.25%). Left ventricular hypertrophy (LVH) was found in 12 cases (9.76%) and, in particular, in hypertensive patients. Prolonged QTc interval was found in 7 patients (5.69%) regardless of the ARV drugs given. this study of HIV-1-infected patients highlights that asymptomatic myocardial ischemia is common. Screening programmes should be improved through more effective ischemia tests in order to better determine its severity in this sub-population with increased cardiovascular risk.

Identifiants

pubmed: 33995780
doi: 10.11604/pamj.2021.38.173.9509
pii: PAMJ-38-173
pmc: PMC8077646
doi:

Substances chimiques

Anti-HIV Agents 0

Types de publication

Case Reports

Langues

fre

Sous-ensembles de citation

IM

Pagination

173

Informations de copyright

Copyright: Jean-Baptiste Tougouma et al.

Déclaration de conflit d'intérêts

Les auteurs ne déclarent aucun conflit d´intérêts.

Références

Circulation. 2009 Feb 17;119(6):770-2
pubmed: 19221228
Clin Infect Dis. 2002 Feb 15;34(4):523-8
pubmed: 11797181
Am J Cardiol. 1991 Sep 15;68(8):729-34
pubmed: 1892078
Bull Soc Pathol Exot. 2002 Mar;95(1):23-6
pubmed: 12012958
AIDS. 2003 Nov 21;17(17):2479-86
pubmed: 14600519
J Acquir Immune Defic Syndr. 2002 Aug 15;30(5):471-7
pubmed: 12154337
Clin Infect Dis. 2007 Oct 15;45(8):1074-81
pubmed: 17879928
N Engl J Med. 2003 Nov 20;349(21):1993-2003
pubmed: 14627784

Auteurs

Jean-Baptiste Tougouma (JB)

Institut Supérieur des Sciences de la Santé (INSSA), Université Polytechnique de Bobo Dioulasso (UPB), Bobo Dioulasso, Burkina Faso.

Arsène Aimé Yaméogo (AA)

Institut Supérieur des Sciences de la Santé (INSSA), Université Polytechnique de Bobo Dioulasso (UPB), Bobo Dioulasso, Burkina Faso.

Nobila Valentin Yaméogo (NV)

Unité de Formation et de Recherche en Sciences de la Santé, Université de Ouagadougou, Ouagadougou, Burkina Faso.

Arsène Hema (A)

Centre Hospitalier Universitaire Sourô Sanou (CHUSS), Bobo Dioulasso, Burkina Faso.

Hervé Hien (H)

Centre Muraz, Bobo-Dioulasso, Burkina Faso.

Yibar Kambiré (Y)

Unité de Formation et de Recherche en Sciences de la Santé, Université de Ouagadougou, Ouagadougou, Burkina Faso.

Armel Poda (A)

Institut Supérieur des Sciences de la Santé (INSSA), Université Polytechnique de Bobo Dioulasso (UPB), Bobo Dioulasso, Burkina Faso.

Jacques Zoungrana (J)

Institut Supérieur des Sciences de la Santé (INSSA), Université Polytechnique de Bobo Dioulasso (UPB), Bobo Dioulasso, Burkina Faso.

Patrice Zabsonré (P)

Unité de Formation et de Recherche en Sciences de la Santé, Université de Ouagadougou, Ouagadougou, Burkina Faso.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH